Current issue #14, 2018

Collisions likely to be generated by anti-US legislative initiative

The first reading of the bill ‘On Measures to Counteract Hostile Acts by the USA and/or Other Foreign States’ is to be held by the Russian State Duma on 15 May. The document was introduced by the leaders of all Duma groups. Clause 15 of the bill imposes ban or restrictions on importing to Russia of the drugs originating from the USA or countries supporting anti-Russian sanctions. When speaking on TV, Deputy Chairman of the State Duma Pyotr Tolstoy proposed using oak bark instead of US drugs.

[PharmVestnik # 14, 24/04/2018, p. 1, cont’d p. 5]

// Government Supported Programs

Pharma companies still interested in government subsidies

The Russian pharma industry has been dynamically developing over the past five years. To maintain the dynamics, not only new targets such as the Pharma-2030 Program but also supportive measures are required. Practice shows that government institutions have a lot to offer businesses. In turn, investors take a lively interest in subsidies and bidding preferences. At the same time, some aspects need a revision.

[PharmVestnik # 14, 24/04/2018, p. 2]

// Regulatory & Legal – General

Pharma to propose solutions for protection of patent rights

Until the Russians start using oak bark instead of US drugs as recommended by State Duma Deputy Pyotr Tolstoy, the issue of protection of patent rights to innovative pharmaceuticals remains pressing. This topic is discussed on a regular basis at authoritative forums. The 10^th Scientific and Practical Conference ‘The State Regulation and Russian Pharmaceutical Industry’2018: Dialogue Continued’ held under the aegis of the Association of Russian Pharmaceutical Manufacturers and Association of International Pharmaceutical Manufacturers was not an exception.

[PharmVestnik # 14, 24/04/2018, p. 3]

// Military-Industrial Complex: Diversification

Experts and officials discussed diversification of military production

Foreign sanctions will not prevent diversification of the Russian military-industrial complex to increase the percentage of civilian industry products in its total output, the more so as the Ministry of Health has already developed the relevant programs and allocated specific funds to implement them. This was the focus of the agenda of the joint meeting of the Interagency Coordination Council of the Military-Industrial Commission Board for the Development of Medical Manufacturing at Military-Industrial Complex Institutions a...